Although BTK was described as a kinase expressed only in bone-marrow-derived cells, more recently, BTK expression has also been detected in various solid tumors, such as those of ovarian cancer, CRC, prostate cancer, and brain cancer, with BTK overexpression being associated with a worse prognosis in the latter [12,21]. Here, BTK is linked to prostate cancer.